Patents Represented by Attorney, Agent or Law Firm Christopher A. Klein
  • Patent number: 5962415
    Abstract: Novel compositions of immunosuppressants, such as cyclosporin, and polypeptide inhibitors of cytoplasmic protein nuclear translocation are disclosed. The compositions have, in addition to at least one immunosuppressant, at least one polypeptide inhibitor of nuclear translocation that has a signal sequence and at least one, preferably two, nuclear localization sequences. The compositions are useful as immunosuppression, antiviral and antitumor agents, preferably to prevent rejection of transplanted organs or tissue.
    Type: Grant
    Filed: May 4, 1998
    Date of Patent: October 5, 1999
    Assignee: Bristol-Myers Squibb Co.
    Inventor: Steven G. Nadler
  • Patent number: 5952217
    Abstract: Yeast cell having the ability to express the kinase domain of N-Pak. The expressed kinase domain restores the mating function of a ste20 mutant and such cells are therefore useful in an assay to screen for inhibitors of N-Pak. Such inhibitors may be useful in treatment and/or prevention of Alzheimer's Disease.
    Type: Grant
    Filed: September 23, 1997
    Date of Patent: September 14, 1999
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jessica A. Gorman, Susan Manly
  • Patent number: 5876950
    Abstract: The present invention provides monoclonal antibodies, antigen binding fragment and recombinant binding proteins specific for human gp39. These antibodies are specific for at least eight different epitopes on gp39. Hybridomas secreting specific antibodies which bind to these epitopes are also provided. Further, the present invention discloses the amino acid sequence of immunoglobulin light and heavy chain variable regions which bind to epitopes of gp39 and provide sFv and humanized antibodies which bind gp39. Also, provided are pharmaceutical compositions comprising the monoclonal antibodies, antigen binding fragments and recombinant binding proteins which bind gp39 and methods for using these compositions in diagnosing disease states, inhibiting B cell activation and for treating immunological disorders, such as autoimmune diseases, allergic responses, organ rejection and graft-versus-host disease.
    Type: Grant
    Filed: January 26, 1995
    Date of Patent: March 2, 1999
    Assignee: Bristol-Myers Squibb Company
    Inventors: Anthony W. Siadak, Diane L. Hollenbaugh, Lisa K. Gilliland, Marcia L. Gordon, Jurgen Bajorath, Alejandro A. Aruffo
  • Patent number: 5869309
    Abstract: The instant invention provides nucleic acid molecules encoding cephalosporin esterase from Rhodosporidium toruloides. In addition, the invention provides isolated cephalosporin esterase, expression vectors, host cells, and methods of producing cephalosporin esterase.
    Type: Grant
    Filed: September 17, 1997
    Date of Patent: February 9, 1999
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Michael Politino, Sean M. Tonzi, John J. Usher, William V. Burnett, Guna Romancik
  • Patent number: 5840307
    Abstract: Hapten-carrier conjugates capable of eliciting anti hapten antibodies in vivo by administering, in a therapeutic composition, are disclosed. Anti-hapten antibodies elicited compete with free hapten upon subsequent challenge of a vaccinated individual. Methods of preparing said conjugates and therapeutic compositions are also disclosed. Where the hapten is a drug of abuse, a therapeutic composition containing the hapten-carrier conjugate is particularly useful in the treatment of drug addiction, more particularly, cocaine addiction. Passive immunization using antibodies raised against conjugates of the instant invention is also disclosed. The therapeutic composition is suitable for co-therapy with other conventional drugs.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: November 24, 1998
    Assignee: ImmuLogic Pharmacuetical Corp.
    Inventors: Philip A. Swain, Victoria Carol Schad, Julia Lea Greenstein, Mark Adrian Exley, Barbara Saxton Fox, Stephen P. Powers, Malcolm L. Gefter
  • Patent number: 5721119
    Abstract: The present invention provides nucleic acid sequences coding for two ryegrass pollen allergen Lol p Ib family members, purified Lol p Ib.1 and Lol p Ib.2 proteins and fragments thereof, methods of producing recombinant Lol p Ib.1 or Lol p Ib.2 or at least one fragment thereof or derivative or homologue thereof, and methods of using the nucleic acid sequences, proteins and peptides of the invention.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: February 24, 1998
    Assignee: University of Melbourne
    Inventors: Mohan Bir Singh, Robert Bruce Knox, Eng Kok Ong
  • Patent number: 5470517
    Abstract: A method of pultrusion is provided that includes the steps of saturating a bundle of fibers in a curable resin, pulling the saturated fibers (also known as "prepreg") into a flexible mold, manipulating the mold (with the saturated fibers therein) into a given shape or form, allowing the saturated fibers to cure or harden, and then removing the flexible mold by mechanical or chemical means. This novel method permits one to mold prepreg into any given shape prior to hardening, not limited by the shape of a given mold or die.
    Type: Grant
    Filed: December 9, 1994
    Date of Patent: November 28, 1995
    Inventor: Ed Conley
  • Patent number: 5427493
    Abstract: A manually operable two-wheeled hand truck is provided, and in particular a hand truck with a pair of gripping extensions capable of spreading horizontally to a desired distance apart without rotation of the gripping extensions about a pivot point.
    Type: Grant
    Filed: December 3, 1993
    Date of Patent: June 27, 1995
    Inventor: Patrick Lucy
  • Patent number: 5359829
    Abstract: A method and apparatus for fabricating a drilled, concrete pier in the earth at a construction site is disclosed. The method comprises the steps of providing a template from which vertical reinforcement bars may be suspended and disposed in spatial alignment generally defining the periphery of the reinforcement cage. All the vertical reinforcement bars of the reinforcement cage are suspended in vertical disposition from the template. Horizontal ties are positioned at selected sides along the length of the reinforcement bars, and are fastened to the vertical reinforcement bars at said sites. In this way, fabrication of the reinforcement cage is completed while the cage is vertically suspended from the template. The reinforcement cage can be fabricated and suspended directly above, and later lowered into, a hole drilled in the earth for a drilled pier foundation.
    Type: Grant
    Filed: December 7, 1992
    Date of Patent: November 1, 1994
    Inventor: John M. Voita
  • Patent number: D343074
    Type: Grant
    Filed: July 16, 1992
    Date of Patent: January 11, 1994
    Inventors: Linda S. Whiteaker, Clayton R. Spillman